Technology | January 13, 2012

FDA Clears Xpress CR Mammography for Sale in U.S.

January 13, 2012 — Konica Minolta Medical Imaging USA announced the U.S. Food and Drug Administration (FDA) cleared the Xpress CR Digital Mammography upgrade for sale.

The clearance specifically applies to the company’s CP1M 18 x 24 and 24 x 30 cassettes and the use of the CS-3 control station with the Regius 190 and 210 readers.

By intelligently recognizing cassette types, the Xpress computed radiography (CR) system delivers digital imaging solutions for both general radiography and mammography application with one easy-to-use, cost-effective solution. The Xpress CR Digital Mammography upgrade provides consistent and reliable high-quality images with the most advanced phosphor receptor available, cesium bromide (CsBr), which delivers a high level of detective quantum efficiency (DQE).

At the heart of this mammography upgrade solution is Konica Minolta’s exclusive ultra high resolution 43.75 um pixel size. This resolution combined with advanced mammography image processing algorithms and specially designed CR Mammography cassettes and plates deliver consistent image quality. Technologists can focus their efforts on patient care due to the simple Xpress CR imaging software and equipment environment.

The CS-3 Control station offers a robust imaging platform which includes specialized imaging tools for CR, digital radiography (DR) and also mammography imaging applications. Specialized mammography algorithms include advanced skin line detection and chest wall masking. These tools combined with the high resolution of the Regius CR reader allow high quality diagnostic mammography images to be acquired, processed, and then transmitted for reading on a diagnostic workstation.

For more information: www.medical.konicaminolta.us

Related Content

FDA Clears Mobilett Elara Max Mobile X-ray from Siemens Healthineers
Technology | Digital Radiography (DR) | March 20, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Mobilett Elara Max mobile X-ray system from Siemens...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
South Dakota's Density Inform Bill Signed Into Law
News | Breast Density | March 06, 2019
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which...
Shimadzu School of Radiologic Sciences Approved at Midwestern State University
News | Digital Radiography (DR) | March 05, 2019
Shimadzu Medical Systems USA (SMS) announced that The Shimadzu School of Radiologic Sciences has been approved by...
iCAD Partnering With Karolinska Instituet Researchers on AI-based Breast Cancer Risk Prediction
News | Oncology Diagnostics | March 04, 2019
iCAD announced their intent to enter an exclusive relationship with two leading researchers at The Karolinska...
Radiologists Quickly Improve Screening Performance With 3-D Mammography
News | Mammography | February 27, 2019
February 27, 2019 — Radiologists quickly learn to read...
Agfa Receives FDA Clearance for DR 800 With Tomosynthesis
Technology | Digital Radiography (DR) | February 21, 2019
Agfa Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its DR 800 multipurpose...
Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits
News | Breast Density | February 20, 2019
The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D.,...
Philips Earns FDA Clearance for DigitalDiagnost C90 DR System
Technology | Digital Radiography (DR) | February 20, 2019
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the...